Plus Therapeutics Inc
NASDAQ:PSTV

Watchlist Manager
Plus Therapeutics Inc Logo
Plus Therapeutics Inc
NASDAQ:PSTV
Watchlist
Price: 0.55 USD -5.17% Market Closed
Market Cap: 75.6m USD

Wall Street
Price Targets

PSTV Price Targets Summary
Plus Therapeutics Inc

There are no price targets for PSTV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Plus Therapeutics Inc Competitors:
Price Targets
SPRY
ARS Pharmaceuticals Inc
141% Upside
CRNX
Crinetics Pharmaceuticals Inc
72% Upside
ALT
Altimmune Inc
411% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
32% Upside
4587
PeptiDream Inc
94% Upside
ORGO
Organogenesis Holdings Inc
66% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
72% Upside
RXRX
Recursion Pharmaceuticals Inc
72% Upside

Revenue
Forecast

Revenue Estimate
Plus Therapeutics Inc

For the last 13 years the compound annual growth rate for Plus Therapeutics Inc's revenue is -4%. The projected CAGR for the next 4 years is 69%.

-4%
Past Growth
69%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Plus Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Plus Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PSTV's stock price target?
Not Available

PSTV doesn't have any price targets made by Wall Street professionals.

What is Plus Therapeutics Inc's Revenue forecast?
Projected CAGR
69%

For the last 13 years the compound annual growth rate for Plus Therapeutics Inc's revenue is -4%. The projected CAGR for the next 4 years is 69%.

Back to Top